Your browser doesn't support javascript.
loading
Insights into the Feasibility and Acceptability of a Mobile Insulin Titration Application in Clinical Practice and Its Effects on Diabetes Outcomes.
Krall, Jodi S; Ng, Jason M; Mehrotra, Neha; Ruppert, Kristine; Siminerio, Linda M.
Afiliación
  • Krall JS; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Ng JM; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Mehrotra N; niversity of Pittsburgh, Department of Medicine, Division of Endocrinology and Metabolism, Pittsburgh, PA, USA.
  • Ruppert K; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Siminerio LM; niversity of Pittsburgh, Department of Medicine, Division of Endocrinology and Metabolism, Pittsburgh, PA, USA.
touchREV Endocrinol ; 20(1): 52-57, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38812671
ABSTRACT

Introduction:

Insulin therapy is most effective if patients learn how to properly adjust insulin to achieve glycaemic targets. There is a need for methods and tools that can assist these processes in clinical practice. The purpose of this feasibility study was to evaluate an approach to support insulin dose adjustment in individual patients using a mobile titration application (app).

Methods:

A cohort of adults (N=36) with type 2 diabetes with suboptimal glycaemia who were starting basal insulin self-titration were trained by a diabetes care and education specialist to use a mobile titration app to guide adjusting insulin doses. Glycaemia, diabetes distress and patient and provider satisfaction were assessed during the first 3 months after initiating basal insulin titration using the mobile app.

Results:

Mean haemoglobin type A1c (HbA1c) was significantly reduced by an average of 2.1 ± 2.2% from baseline to 3 months (p<0.001). Diabetes distress significantly decreased from baseline to follow-up with scores going down (or improving) across all scales. Both patients and providers reported high levels of satisfaction and positive experiences.

Conclusion:

The model offers a promising solution to streamline insulin dosage adjustments to achieve specific clinical and self-management goals with high expectations for long-term benefits and warrants further investigation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: TouchREV Endocrinol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: TouchREV Endocrinol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido